Usa India covid-19 innovations medicines Usa India

US tries to thwart TRIPS flexibilities in the midst of a pandemic

Reading now: 797
www.livemint.com

While covid-19 is prompting countries to consider exercising flexibilities in the World Trade Organization’s TRIPS (trade-related aspects of intellectual property rights) agreement for facilitating the supply of affordable and effective medicines to patients, the recently-released Special 301 Report by the United States Trade Representative (USTR) exhibits a neglect of the difficulties that countries are going through.

India continues to be placed on the USTR’s “Priority Watch List". US regulations empower the USTR to pursue a course of action that would elicit a favourable response from countries placed on this list.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA